BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8904321)

  • 21. Dosing time-dependent variation of bone resorption by cyclosporin A in rats' femurs.
    Tsuruoka S; Kaneda T; Maeda A; Ioka T; Fujimura A
    Eur J Pharmacol; 2007 Jun; 564(1-3):226-31. PubMed ID: 17362919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of heparin on osteoclast activity.
    Chowdhury MH; Hamada C; Dempster DW
    J Bone Miner Res; 1992 Jul; 7(7):771-7. PubMed ID: 1642146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cyclosporine on osteoclast activity: inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity.
    Williams JP; McKenna MA; Thames AM; McDonald JM
    J Bone Miner Res; 2003 Mar; 18(3):451-7. PubMed ID: 12619929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between calcium accumulation in osteoclast mitochondrial granules and bone resorption.
    Kawahara I; Koide M; Tadokoro O; Udagawa N; Nakamura H; Takahashi N; Ozawa H
    Bone; 2009 Nov; 45(5):980-6. PubMed ID: 19631304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiol oxidation and cytochrome P450-dependent metabolism of CCl4 triggers Ca2+ release from liver microsomes.
    Stoyanovsky DA; Cederbaum AI
    Biochemistry; 1996 Dec; 35(49):15839-45. PubMed ID: 8961948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of propagation of intracellular calcium waves in cultured human uterine myocytes.
    Young RC; Zhang P
    Am J Obstet Gynecol; 2001 May; 184(6):1228-34. PubMed ID: 11349193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodeling in the rat.
    Klapisz-Wolikow M; Saffar JL
    J Cell Physiol; 1996 May; 167(2):359-68. PubMed ID: 8613479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts.
    Kajiya H; Okabe K; Okamoto F; Tsuzuki T; Soeda H
    J Cell Physiol; 2000 Apr; 183(1):83-90. PubMed ID: 10699969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different calcium sensitivity in osteoclasts on glass and on bone and maintenance of cytoskeletal structures on bone in the presence of high extracellular calcium.
    Lakkakorpi PT; Lehenkari PP; Rautiala TJ; Väänänen HK
    J Cell Physiol; 1996 Sep; 168(3):668-77. PubMed ID: 8816921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
    Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G
    J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ruthenium red-mediated inhibition of large-conductance Ca2+-activated K+ channels in rat pituitary GH3 cells.
    Wu SN; Jan CR; Li HF
    J Pharmacol Exp Ther; 1999 Sep; 290(3):998-1005. PubMed ID: 10454470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption.
    Alam AS; Gallagher A; Shankar V; Ghatei MA; Datta HK; Huang CL; Moonga BS; Chambers TJ; Bloom SR; Zaidi M
    Endocrinology; 1992 Jun; 130(6):3617-24. PubMed ID: 1597159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of ruthenium red, an inhibitor of calcium-induced calcium release, on phasic myometrial contractions.
    Phillippe M; Basa A
    Biochem Biophys Res Commun; 1996 Apr; 221(3):656-61. PubMed ID: 8630017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological activity of chicken calcitonin: effects on neonatal rat and embryonic chick osteoclasts.
    Dempster DW; Murrills RJ; Horbert WR; Arnett TR
    J Bone Miner Res; 1987 Oct; 2(5):443-8. PubMed ID: 3455627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ethanol on bone cells in vitro resulting in increased resorption.
    Cheung RC; Gray C; Boyde A; Jones SJ
    Bone; 1995 Jan; 16(1):143-7. PubMed ID: 7742073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural localization of concanavalin-A binding sites on bone cells: effects of con A on osteoclastic bone resorption.
    Popoff SN; Schneider GB
    Scan Electron Microsc; 1983; (Pt 2):959-67. PubMed ID: 6635581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet activating factor increases intracellular calcium in isolated osteoclasts but does not modify bone resorption.
    Wucherpfennig AL; Dewhirst FE; Stashenko P
    Bone; 1993; 14(1):13-8. PubMed ID: 8442997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.